1. Li, H, Wu, D K, Sullivan, S L. . Characterization and expression of sema4g, a novel member of the semaphorin gene family. In Mechanisms of development, 87, 169-73. doi:. https://pubmed.ncbi.nlm.nih.gov/10495281/
2. Maier, Viola, Jolicoeur, Christine, Rayburn, Helen, Wurst, Wolfgang, Friedel, Roland H. 2010. Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development. In Molecular and cellular neurosciences, 46, 419-31. doi:10.1016/j.mcn.2010.11.005. https://pubmed.ncbi.nlm.nih.gov/21122816/
3. Shen, Zhen, Sun, Yingjun, Niu, Guohua. 2023. Variants in TPO rs2048722, PTCSC2 rs925489 and SEMA4G rs4919510 affect thyroid carcinoma susceptibility risk. In BMC medical genomics, 16, 19. doi:10.1186/s12920-023-01447-5. https://pubmed.ncbi.nlm.nih.gov/36737753/
4. Wu, Shuangshuang, Yuan, Weiyan, Shen, Yu, Wu, Jianqing, Chu, Minjie. . The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 39, 1010428317703819. doi:10.1177/1010428317703819. https://pubmed.ncbi.nlm.nih.gov/28653886/
5. Barr, Julie L, Feehan, Michael, Tak, Casey, Brilliant, Murray H, DeAngelis, Margaret M. 2023. Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence. In International journal of molecular sciences, 24, . doi:10.3390/ijms24065636. https://pubmed.ncbi.nlm.nih.gov/36982708/